Accessibility Menu
Diaceutics Plc logo

Diaceutics Plc

(LSE) DXRX

Current Price£1.48
Market Cap£123.43M
Since IPO (2019)+53%
5 Year+16%
1 Year+27%
1 Month-12%

Diaceutics Plc Financials at a Glance

Market Cap

£123.43M

Revenue (TTM)

£70.60M

Net Income (TTM)

-£1.61M

EPS (TTM)

£0.00

P/E Ratio

1327.27

Dividend

£0.00

Beta (Volatility)

-0.03 (Low)

Price

£1.48

Volume

9,400

Open

£1.48

Previous Close

£1.45

Daily Range

£1.48 - £1.48

52-Week Range

£1.12 - £1.80

Estimated Earnings Date

Sep 29, 2026

DXRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Diaceutics Plc

Industry

Life Sciences Tools and Services

Employees

205

CEO

Ryan Gerard Keeling

Headquarters

Belfast, BT9 6GW, GB

DXRX Financials

Key Financial Metrics (TTM)

Gross Margin

74%

Operating Margin

-1%

Net Income Margin

0%

Return on Equity

24%

Return on Capital

-1%

Return on Assets

0%

Earnings Yield

0.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£123.43M

Shares Outstanding

84.54M

Volume

9.40K

Avg. Volume

197.41K

Financials (TTM)

Gross Profit

£26.12M

Operating Income

£266.00K

EBITDA

£6.08M

Operating Cash Flow

£1.50M

Capital Expenditure

-£71.00K

Free Cash Flow

£1.43M

Cash & ST Invst.

£7.34M

Total Debt

£1.15M

Diaceutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£23.87M

+73.3%

Gross Profit

£16.28M

+47.9%

Gross Margin

68.20%

N/A

Market Cap

£123.43M

N/A

Market Cap/Employee

£670.83K

N/A

Employees

184

N/A

Net Income

£2.50M

+1057.1%

EBITDA

£6.25M

+167.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£7.34M

-55.9%

Total Debt

£1.15M

-4.4%

Accounts Receivable

£20.97M

+107.1%

Inventory

£0.00

N/A

Long Term Debt

£882.00K

-16.7%

Short Term Debt

£270.00K

-7.5%

Return on Assets

0.19%

N/A

Return on Invested Capital

-0.51%

N/A

Free Cash Flow

£680.00K

+23.9%

Operating Cash Flow

£696.00K

+13.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EKF.LEKF Diagnostics Holdings plc
£0.26-1.40%
BVXP.LBioventix PLC
£17.61-3.51%
VLG.LVenture Life Group plc
£0.66-0.75%
OPT.LOptima Health plc
£1.92-0.04%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$185.00-0.04%
MRVLMarvell Technology
$310.58+0.07%
NOKNokia
$13.49-0.02%
AALAmerican Airlines Group
$15.99+0.04%

Questions About DXRX

What is the current price of Diaceutics Plc?

Diaceutics Plc is trading at £1.48 per share.

What is the 52-week range for Diaceutics Plc?

Over the past 52 weeks, Diaceutics Plc has traded between £1.12 and £1.80.

How much debt does Diaceutics Plc have?

As of the most recent reporting period, Diaceutics Plc reported total debt of £1.15M.

How much cash does Diaceutics Plc have on hand?

Diaceutics Plc reported £7.34M in cash and cash equivalents in its most recent financial results.

What is Diaceutics Plc’s dividend yield?

Diaceutics Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.